ArticleDiagnostic pathology2023

DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients.

Weiguang Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.